“We use Leronlimab if we could get it”
Oh really?
Quote:> Long-hauler protocol submission didn’t happen, debate about PE, modifying protocol, “hopefully” submit to FDA next week: 100 patients, 1:1 randomisation, fast enrolment, since no competition; holding off on Phase 3 moderate; all focus on CD-12
Read More: https://investorshangout.com/post/view?id=595...z6cy6v0F7K